Product highlights
- The FY2025 manufacturer filing explicitly says Ion commercialization in 2019. FDA K182188 records an initial February 14, 2019 decision, and later IF1000 changes remain version-specific; dates of 2025 updates are not Ion’s first release.
- IF1000 separates a PlanPoint planning laptop, system cart with instrument arm/monitors, physician controller, articulating catheter, vision probe and biopsy tools. The planning computer/software, Flexision needles and accessories are not independently established new robot chassis.
- The physician controls catheter navigation in a leader–follower architecture using endoscopic viewing and a CT-derived airway model. Real-time shape sensing is not autonomous biopsy, an exact metric error bound or proof every lesion is reached or diagnosed.
- The manufacturer describes catheter articulation through 180 degrees, a component movement envelope rather than full-system DOF or robot body size. Catheter/channel diameters, biopsy-needle gauge and instrument/tray weight are not copied into full-platform size, cargo or vision-accuracy fields.
- The September 2025 K252045 submission and FDA query retain the IF1000 identity and distinguish system/software/accessory updates. The selected October 19, 2026 dataset has 11 matching Ion records; that query count is not 11 robots or an exhaustive current worldwide authorization register.
Product sources
- Intuitive Surgical — company-authored FY2025 Form 10-K hosted by SEC; products, commercialization history and business model · Manufacturer source · Checked 2026-11-02
- Intuitive Surgical — Intuitive Ion IF1000 submission in FDA K182188 record, initial 2019 architecture · Manufacturer source · Checked 2026-11-02
- Intuitive Surgical — Intuitive Ion IF1000 submission in FDA K252045 record, September 2025 update and architecture · Manufacturer source · Checked 2026-11-02
- FDA — FDA openFDA Ion query; all 11 matching records in October 19, 2026 dataset snapshot · Regulatory authority source · Checked 2026-11-02
Description
Ion is Intuitive’s IF1000 robotic-assisted endoluminal platform commercialized in 2019, separate from the da Vinci surgical systems. The manufacturer submissions describe a PlanPoint planning laptop using chest CT data, system cart, physician controller, fully articulating catheter, vision probe and biopsy tools. Real-time shape sensing supports catheter navigation; catheter articulation is not whole-robot DOF, metric navigation accuracy or guaranteed diagnostic yield. No numeric complete-system mass, outer size, cargo, battery endurance, charge duration or motion-accuracy guarantee is established. Clinical indications and compatible tools vary by system, version and jurisdiction; no autonomous surgery or guaranteed clinical outcome is claimed.
Specifications
Sources cover the marked fields only. Unmarked values have not been checked in this review; manufacturer figures are not independent test results.
| Drive modeSource review · | Physician controller commands IF1000 catheter through a leader–follower system with CT-derived planning and real-time shape sensing; not autonomous biopsy |
| TerrainSource review · | Clinician-operated endoluminal pulmonary platform in a clinical setting; no numeric environmental envelope established |
| Release DateSource review · | 2019 |